Page last updated: 2024-08-21
2'-deoxyadenosine triphosphate and Granulocytic Leukemia, Chronic
2'-deoxyadenosine triphosphate has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Alvarado, Y; Brown, RA; Cahill, A; Cortes, JE; DiPersio, JF; Faderl, S; Fracasso, PM; Gandhi, V; Garcia-Manero, G; Giles, FJ; Kantarjian, HM; Lambert, P; Plunkett, W; Samson, T; Sznol, M; Thomas, DA; Verstovsek, S; Wright, LP | 1 |
Trials
1 trial(s) available for 2'-deoxyadenosine triphosphate and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia.
Topics: Adult; Aged; Aged, 80 and over; Deoxyadenine Nucleotides; Deoxyguanine Nucleotides; DNA; DNA, Neoplasm; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Middle Aged; Pyridines; Ribonucleotide Reductases; Safety; Thiosemicarbazones | 2003 |